Cardiovascular Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Surgical Procedures, Interventional Procedures, Non-invasive Procedures), By Indication (Ischemic Heart Disease), By Care Setting, By Region, And Segment Forecasts, 20
Description
Cardiovascular Treatment Market Summary
The global cardiovascular treatment market size was estimated at USD 241.18 billion in 2024 and is projected to reach USD 383.11 billion by 2033, growing at a CAGR of 5.1% from 2025 to 2033. This market growth is driven by the rising prevalence of cardiovascular diseases (CVDs) such as coronary artery disease, stroke, heart failure, and hypertension, fueled by sedentary lifestyles, poor dietary habits, obesity, and an aging global population.
Increasing awareness of heart health and early diagnosis, coupled with advancements in diagnostic imaging, interventional cardiology, and minimally invasive surgical techniques, accelerating treatment adoption. Moreover, technological innovations such as drug-eluting stents, bioresorbable vascular scaffolds, and novel anticoagulant therapies are enhancing patient outcomes and expanding clinical applications.
Global Cardiovascular Treatment Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cardiovascular treatment market report based on treatment type, indication, care setting, and region.
The global cardiovascular treatment market size was estimated at USD 241.18 billion in 2024 and is projected to reach USD 383.11 billion by 2033, growing at a CAGR of 5.1% from 2025 to 2033. This market growth is driven by the rising prevalence of cardiovascular diseases (CVDs) such as coronary artery disease, stroke, heart failure, and hypertension, fueled by sedentary lifestyles, poor dietary habits, obesity, and an aging global population.
Increasing awareness of heart health and early diagnosis, coupled with advancements in diagnostic imaging, interventional cardiology, and minimally invasive surgical techniques, accelerating treatment adoption. Moreover, technological innovations such as drug-eluting stents, bioresorbable vascular scaffolds, and novel anticoagulant therapies are enhancing patient outcomes and expanding clinical applications.
Global Cardiovascular Treatment Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cardiovascular treatment market report based on treatment type, indication, care setting, and region.
- Treatment Type Outlook (Revenue, USD Million, 2021 - 2033)
- Surgical Procedures
- Coronary Artery Bypass Grafting (CABG)
- Valve Repair/Replacement
- Heart Transplant Surgery
- Others
- Interventional Procedures
- Percutaneous Coronary Intervention (PCI)
- Angioplasty
- Transcatheter Aortic Valve Replacement (TAVR)
- Others
- Non-invasive Procedures
- Cardiac Rehabilitation
- Physical Therapy and Lifestyle Intervention
- Others
- Indication Outlook (Revenue, USD Million, 2021 - 2033)
- Ischemic Heart Disease (IHD)
- Heart Failure & Cardiomyopathies
- Cardiac Arrhythmias & Conduction Disorders
- Structural Heart & Valvular Disease
- Others
- Care Setting Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Outpatient Facilities
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR’s Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.3.5. Details of Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.5.1. Commodity Flow Analysis
- 1.6. Data Validation & Publishing
- 1.7. List of Secondary Sources
- 1.8. Research Objectives
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segmental Snapshot
- 2.3. Competitive Insights Snapshot
- Chapter 3. Market Variables, Trends, and Scope
- 3.1. Market Lineage
- 3.1.1. Parent Market Analysis
- 3.1.2. Ancillary Market Analysis
- 3.2. Cardiovascular Treatment Market- Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environmental Tools Analysis: Cardiovascular Treatment Market
- 3.3.1. Porter’s Five Forces Analysis
- 3.3.2. PESTLE Analysis
- Chapter 4. Cardiovascular Treatment Market: Treatment Type Estimates & Trend Analysis
- 4.1. Cardiovascular Treatment Market, By Treatment Type: Key Takeaways
- 4.2. Cardiovascular Treatment Market: Treatment Type Movement & Market Share Analysis, 2024 & 2033
- 4.3. Surgical Procedures
- 4.3.1. Surgical Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.2. Coronary Artery Bypass Grafting (CABG)
- 4.3.2.1. Coronary Artery Bypass Grafting (CABG) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.3. Valve Repair/Replacement
- 4.3.3.1. Valve Repair/Replacement Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.4. Heart Transplant Surgery
- 4.3.4.1. Heart Transplant Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3.5. Others
- 4.3.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4. Interventional Procedures
- 4.4.1. Interventional Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Percutaneous Coronary Intervention (PCI)
- 4.4.2.1. Percutaneous Coronary Intervention (PCI) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Angioplasty
- 4.4.3.1. Angioplasty Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Transcatheter Aortic Valve Replacement (TAVR)
- 4.4.4.1. Transcatheter Aortic Valve Replacement (TAVR) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.5. Others
- 4.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Non-invasive Procedures
- 4.5.1. Non-invasive Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.2. Cardiac Rehabilitation
- 4.5.2.1. Cardiac Rehabilitation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.3. Physical Therapy and Lifestyle Intervention
- 4.5.3.1. Physical Therapy and Lifestyle Intervention Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5.4. Others
- 4.5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Cardiovascular Treatment Market: Indication Estimates & Trend Analysis
- 5.1. Cardiovascular Treatment Market, By Indication: Key Takeaways
- 5.2. Cardiovascular Treatment Market: Indication Movement & Market Share Analysis, 2024 & 2033
- 5.3. Ischemic Heart Disease (IHD)
- 5.3.1. Ischemic Heart Disease (IHD) Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4. Heart Failure & Cardiomyopathies
- 5.4.1. Heart Failure & Cardiomyopathies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Cardiac Arrhythmias & Conduction Disorders
- 5.5.1. Cardiac Arrhythmias & Conduction Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Structural Heart & Valvular Disease
- 5.6.1. Structural Heart & Valvular Disease Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Others
- 5.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Cardiovascular Treatment Market: Care Setting Estimates & Trend Analysis
- 6.1. Cardiovascular Treatment Market, By Care Setting: Key Takeaways
- 6.2. Cardiovascular Treatment Market: Care Setting Movement & Market Share Analysis, 2024 & 2033
- 6.3. Hospitals
- 6.3.1. Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4. Outpatient Facilities
- 6.4.1. Outpatient Facilities Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Cardiovascular Treatment Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2024 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. North America
- 7.4.1. U.S.
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Regulatory framework
- 7.4.1.3. Competitive scenario
- 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.2. Canada
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework
- 7.4.2.3. Competitive scenario
- 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.3. Mexico
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework
- 7.4.3.3. Competitive scenario
- 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5. Europe
- 7.5.1. UK
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework
- 7.5.1.3. Competitive scenario
- 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.2. Germany
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive scenario
- 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.3. France
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive scenario
- 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.4. Italy
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.5. Spain
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework
- 7.5.5.3. Competitive scenario
- 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.6. Norway
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.7. Sweden
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Regulatory framework
- 7.5.7.3. Competitive scenario
- 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.8. Denmark
- 7.5.8.1. Key country dynamics
- 7.5.8.2. Regulatory framework
- 7.5.8.3. Competitive scenario
- 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Japan
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework
- 7.6.1.3. Competitive scenario
- 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.2. China
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework
- 7.6.2.3. Competitive scenario
- 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.3. India
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework
- 7.6.3.3. Competitive scenario
- 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.4. Australia
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework
- 7.6.4.3. Competitive scenario
- 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.5. South Korea
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework
- 7.6.5.3. Competitive scenario
- 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.6. Thailand
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework
- 7.6.6.3. Competitive scenario
- 7.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7. Latin America
- 7.7.1. Brazil
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework
- 7.7.1.3. Competitive scenario
- 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7.2. Argentina
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8. MEA
- 7.8.1. South Africa
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Regulatory framework
- 7.8.1.3. Competitive scenario
- 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.2. Saudi Arabia
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework
- 7.8.2.3. Competitive scenario
- 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.3. UAE
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Regulatory framework
- 7.8.3.3. Competitive scenario
- 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 7.8.4. Kuwait
- 7.8.4.1. Key country dynamics
- 7.8.4.2. Regulatory framework
- 7.8.4.3. Competitive scenario
- 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Key company market position analysis, 2024
- 8.4. List of Companies
- 8.4.1. The Johns Hopkins Hospital
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Service benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Cleveland Clinic
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Service benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Icahn School of Medicine at Mount Sinai
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Service benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Toronto General Hospital (University Health Network)
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Service benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Sagar Hospitals
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Service benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Sagar Hospitals
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Service benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. Medanta The Medicity
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Service benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. The University of Tokyo Hospital
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Service benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Royal Papworth Hospital NHS Foundation Trust
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Service benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. London Bridge Hospital (HCA Healthcare UK)
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Service benchmarking
- 8.4.10.4. Strategic initiatives
- 8.4.11. Burjeel Hospital
- 8.4.11.1. Company overview
- 8.4.11.2. Financial performance
- 8.4.11.3. Service benchmarking
- 8.4.11.4. Strategic initiatives
- 8.4.12. King’s College Hospital NHS Foundation Trust
- 8.4.12.1. Company overview
- 8.4.12.2. Financial performance
- 8.4.12.3. Service benchmarking
- 8.4.12.4. Strategic initiatives
- 8.4.13. Beneficente Israelita Brasileira Albert Einstein
- 8.4.13.1. Company overview
- 8.4.13.2. Financial performance
- 8.4.13.3. Service benchmarking
- 8.4.13.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
